Dr. Harvey Risch, Dr. Zev Zelenko, early treatment, Faucy, HCQ "science war", heard immunity, hydroxychloroquine and azithromycin (HCQ-AZ), IHU Méditerranée-Infection, inpatients, outpatients, the corruption of the medical peer-review process, the crime that led to the banning of HCQ, the fake Surgisphere papers, the suppression of early treatment
Dr. Harvey Risch, MD, PhD, Professor of Epidemiology Yale University.
Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients That Should Be Ramped Up Immediately as Key to the Pandemic Crisis — Harvey A Risch
American Journal of Epidemiology, Volume 189, Issue 11, November 2020, Pages 1218–1226, https://doi.org/10.1093/aje/kwaa093 Published: 27 May 2020
Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
Published: June 05, 2020DOI: https://doi.org/10.1016/S0140-6736(20)31324-6
[Link to the retracted paper: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31180-6/fulltext%5D
C) Norm’s note: reference to the “Magic paper” that Dr. Risch heavily criticizes (or rather — shreds):
The Magic of Randomization versus the Myth of Real-World Evidence
List of authors.
- Rory Collins, F.R.S.,
- Louise Bowman, M.D., F.R.C.P.,
- Martin Landray, Ph.D., F.R.C.P.,
- and Richard Peto, F.R.S.
Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials
The Environment and Disease: Association or Causation?
Proc R Soc Med. 1965 May; 58(5): 295–300.
Junk Studies reviewed by Dr. Risch:
Boulware et al. (University of Minnesota)
Skipper et al. (University of Minnesota)
Mitjà et al. (Catalonia RCT of individuals)
Mitjà et al. (Catalonia cluster-randomized trial)
Schwartz et al. (Alberta, Canada)